Numbers for Pharma arm of Aarti Industries 👇
Revenue for Pharma growing faster than Specialty Chemicals.
Pharma CAGR at 20% vs Spec Chem at 13%
EBIT too growing much faster for Pharma vs Spec Chem
Pharma EBIT CAGR at 44% vs Specialty Chemical EBIT CAGR of 7%
Pharma Revenue and EBIT QoQ
New capacities for Pharma coming up in H2FY22
Growth area focus towards API and Intermediates for regulated markets
Commentary
Link to PPT: bseindia.com/xml-data/corpf…
Continue to read more.
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.